reNeu Biotechnology Research Institute Advisory Board

Director of the Stem Cell Platform and
Clinical Medicine Professor at Peking Union Medical College Hospital,
Chinese Academy of Medical Sciences
Advisor, reNeu Biotechnology Research Institute

Chief Physician of Orthopedics at Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Professor, PhD supervisor in Clinical Medicine and Biomedical Engineering, Director of the Stem Cell Platform and Director of the Experimental Animal Center at Peking Union Medical College Hospital, Deputy Director of the Clinical Medical Research Institute of the Chinese Academy of Medical Sciences, and Deputy Director of the Beijing Key Laboratory of Genetic Research on Skeletal Malformations.
Editorial board member of the Chinese Journal of Bone and Joint Surgery and a member of the Bone Tissue Bank Branch of the Chinese Association of Medical Biotechnology. Engaged in basic and clinical research on common and frequently occurring orthopedic diseases for a long time, guiding the research work of over 40 master’s and doctoral students; coordinating and organizing the application and implementation of more than 40 various research funds from different sources. Currently undertaking a project on industry-university-research cooperation supported by the Beijing Education Commission, and has participated in multiple research efforts, such as the Ministry of Health’s key discipline construction project, the multi-disciplinary “Ninety-Five” National Medical Science and Technology Key Project, “Fifteen” National Science and Technology Key Project topics, National Support Program projects, specific research topics funded by health care, scientific funds from the Ministry of Health, Beijing Science and Technology Commission funds, doctoral funding, and internal hospital funds. He has published over 100 articles and contributed to the writing of works such as “New Surgical Techniques in Spine Surgery”
(Second Edition), “Modern Surgery,” and “Surgical Science of Scoliosis.” He has received the Second Prize of the Chinese Medical Science and Technology Award in 2004, the Second Prize of the Beijing Science and Technology Award in 2004, and the Second Prize of the National Science and Technology Award in 2005.”

Doctor of Economics, Professor
Founder and Chairman of Hexie Technology
Advisor, reNeu Biotechnology Research Institute

Doctor of Economics, Professor, and PhD supervisor. Founder, Chairman, and General Manager of Hexie Technology Co., Ltd. Previously worked at the Hospital Management Institute of the Ministry of Health, the Central Committee of the China National Democratic Construction Association, and the Primary Health Care Foundation of China.

Chairman and Senior Researcher
European Wellness Biomedical Group
Advisor, reNeu Biotechnology Research Institute

Prof. Dato Sri Dr. Mike K.S. Chan, is a pioneer of Cellular, Organo and Cell Membrane Therapies in Europe and Asia since the earl y 1980’s. He founded one of the world’s largest research groups of Bio-Molecular Medicine based in Switzerland and Germany wih a global presence in almost eighty countries. He has conducted more than 1,000 lectures, seminars, and symposiums worldwide in the fields of antiaging, cell regeneration, bio-re-generative medicine, and stemcell therapies. Author & co-author of numerous books and articles in the fields of cell therapy, immunology, bio-regenerative sciences, nutrition, and innovator of cellular based nutraceuticals &cosmeceuticals, Prof. Mike Chan is also the founder of European Wellness Biomedical Group-an International chain of research and treatment facilities (European Wellness Centers & Retreats) in-volved in anti-aging, longevity and education (European Wellness Academy). He chairs and also sits on board on numerous prominent antiaging and cell therapy associations of the world.